Literature DB >> 9075300

Cognitive and symptom correlates of participation in social skills training groups.

M McKee1, J W Hull, T E Smith.   

Abstract

In a study of 19 hospitalized chronic schizophrenic patients participating in a manualized skills training program, neuropsychological functioning was found to be an important mediating variable. Executive functioning capacity was positively associated with level of participation in the training groups, and deficits in sustained attention together with negative symptoms correlated negatively with overall program attendance. Neuropsychological functioning should be considered as an important assessment domain when identifying patients with minimal requirements to begin skills training.

Entities:  

Mesh:

Year:  1997        PMID: 9075300     DOI: 10.1016/s0920-9964(96)00090-4

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  5 in total

1.  [Neuropsychology of psychoeducation in schizophrenia: results of the Munich COGPIP study].

Authors:  G Pitschel-Walz; A Gsottschneider; T Froböse; S Kraemer; J Bäuml; T Jahn
Journal:  Nervenarzt       Date:  2013-01       Impact factor: 1.214

2.  Social skills training and computer-assisted cognitive remediation in schizophrenia.

Authors:  Matthew M Kurtz; Kim T Mueser; Warren R Thime; Silvia Corbera; Bruce E Wexler
Journal:  Schizophr Res       Date:  2015-01-29       Impact factor: 4.939

Review 3.  Neurocognition as a predictor of response to evidence-based psychosocial interventions in schizophrenia: what is the state of the evidence?

Authors:  Matthew M Kurtz
Journal:  Clin Psychol Rev       Date:  2011-02-26

4.  Neuropsychological predictors of functional outcome in Cognitive Behavioral Social Skills Training for older people with schizophrenia.

Authors:  Eric Granholm; John R McQuaid; Peter C Link; Scott Fish; Thomas Patterson; Dilip V Jeste
Journal:  Schizophr Res       Date:  2008-01-28       Impact factor: 4.939

5.  Cognitive deficits and functional outcome in schizophrenia.

Authors:  Christopher R Bowie; Philip D Harvey
Journal:  Neuropsychiatr Dis Treat       Date:  2006-12       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.